Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BOSTON SCIENTIFIC CORP Director's Dealing 2015

Feb 25, 2015

29821_dirs_2015-02-25_0d8b1612-d7de-42c5-bffd-6e36506ed27c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2015-02-23

Reporting Person: Prange Karen (SVP&Pres, Uro & Women's Health)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-02-23 Deferred Stock Units $ A 11496.0000 Acquired 2020-02-23 Common Stock (11496.0000) Direct
2015-02-23 Performance Share Units $ A 10701.0000 Acquired 2016-12-31 Common Stock (10701.0000) Direct
2015-02-23 Stock Option (Right to Buy) $16.3100 A 32327.0000 Acquired 2025-02-23 Common Stock (32327.0000) Direct

Footnotes

F1: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.

F2: Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 23, 2016, the first anniversary of the date of grant.

F3: Each performance share unit represents the Company's commitment to issue one share of Boston Scientific common stock.

F4: On February 24, 2014, the reporting person was awarded a target number of performance share units under the Company's 2014 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person based on the Company's 2014 adjusted free cash flow measured against its 2014 financial plan over the one-year performance period ending December 31, 2014 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 23, 2015, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined will vest in whole upon the completion of the individual service period that ends on December 31, 2016.

F5: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 23, 2016, the first anniversary of the date of grant.